Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma

Clinical Biochemistry

Volumn 42, Issue 10-11, 2009, Pages 1046-1050

  Grigoriu, Bogdan ^a,e   Chahine, Bachar ^b   Zerimech, Farid ^b   Grégoire, Marc ^c   Balduyck, Malika ^b,d   Copin, Marie Christine ^b   Devos, Patrick ^d   Lassalle, Philippe ^a   Scherpereel, Arnaud ^a,b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d UNIV LILLE   (France)

^e GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Diagnosis; Hyaluronic acid; Marker; Mesothelin mesothelioma; Pleural effusion

Indexed keywords

BIOCHEMICAL MARKER; HYALURONIC ACID; MESOTHELIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASBESTOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; PLEURA EFFUSION; PLEURA FLUID; PLEURA METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROC CURVE; SENSITIVITY ANALYSIS;

AGED; FEMALE; HUMANS; HYALURONIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MESOTHELIOMA; PLEURAL EFFUSION;

EID: 67349283784     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.03.007     Document Type: Article

References (20)

1. Ordonez N.G. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum. Pathol. 38 1 (2007) 1-16
2. Chatterjee S.K., and Zetter B.R. Cancer biomarkers: knowing the present and predicting the future. Future Oncol. 1 1 (2005) 37-50
3. Frebourg T., Lerebours G., Delpech B., et al. Serum hyaluronate in malignant pleural mesothelioma. Cancer 59 12 (1987) 2104-2107
4. Boersma A., Degand P., and Biserte G. Hyaluronic acid analysis and the diagnosis of pleural mesothelioma. Bull. Eur. Physiopathol. Respir. 16 1 (1980) 41-45
5. Chiu B., Churg A., Tengblad A., Pearce R., and McCaughey W.T. Analysis of hyaluronic acid in the diagnosis of malignant mesothelioma. Cancer 54 10 (1984) 2195-2199
6. Fuhrman C., Duche J.C., Chouaid C., et al. Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin. Biochem. 33 5 (2000) 405-410
7. Soderblom T., Pettersson T., Nyberg P., et al. High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur. Respir. J. 13 3 (1999) 519-522
8. Atagi S., Ogawara M., Kawahara M., et al. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn. J. Clin. Oncol. 27 5 (1997) 293-297
9. Martensson G., Thylen A., Lindquist U., and Hjerpe A. The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73 5 (1994) 1406-1410
10. Thylen A., Hjerpe A., and Martensson G. Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 92 5 (2001) 1224-1230
11. Robinson B.W., Creaney J., Lake R., et al. Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362 9396 (2003) 1612-1616
12. Scherpereel A., Grigoriu B.D., Conti M., et al. Soluble mesothelin-related protein in the diagnosis of malignant pleural mesothelioma. Am. J. Respir. Crit. Care Med. 173 (2006) 1155-1160
13. Grigoriu B.D., Scherpereel A., Devos P., et al. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin. Cancer Res. 13 10 (2007) 2928-2935
14. Chichibu K., Matsuura T., Shichijo S., and Yokoyama M.M. Assay of serum hyaluronic acid in clinical application. Clin. Chim. Acta 181 3 (1989) 317-323
15. Galateau-Sallé F.E. Pathology of malignant mesothelioma. 1st edition ed. 204 (2006), Springer-Verlag, New York
16. Conover W.J., and Iman R.L. Analysis of covariance using the rank transformation. Biometrics 38 3 (1982) 715-724
17. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 3 (1983) 839-843
18. Welker L., Muller M., Holz O., et al. Cytological diagnosis of malignant mesothelioma-improvement by additional analysis of hyaluronic acid in pleural effusions. Virchows Arch. 450 4 (2007) 455-461
19. van den Heuvel M.M., Korse C.M., Bonfrer J.M.G., and Baas P. Non-invasive diagnosis of pleural malignancies: the role of tumour markers. Lung Cancer 59 3 (2008) 350-354
20. Creaney J., van Bruggen I., Hof M., et al. Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest 132 4 (2007) 1239-1246